Arcturus Therapeutics Holdings Inc banner

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 7.85 USD 1.68% Market Closed
Market Cap: $223.1m

Wall Street
Price Targets

ARCT Price Targets Summary
Arcturus Therapeutics Holdings Inc

Wall Street analysts forecast ARCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARCT is 25.78 USD with a low forecast of 8.08 USD and a high forecast of 71.4 USD.

Lowest
Price Target
8.08 USD
3% Upside
Average
Price Target
25.78 USD
228% Upside
Highest
Price Target
71.4 USD
810% Upside
Arcturus Therapeutics Holdings Inc Competitors:
Price Targets
RLMD
Relmada Therapeutics Inc
106% Upside
VNOM
Viper Energy Partners LP
19% Upside
NN
NextNav Inc
28% Upside
FLEX
Flex Ltd
12% Upside

Revenue
Forecast

N/A
Past Growth
-18% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
-18% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 3 years is -18%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARCT's stock price target?
Price Target
25.78 USD

According to Wall Street analysts, the average 1-year price target for ARCT is 25.78 USD with a low forecast of 8.08 USD and a high forecast of 71.4 USD.

What is Arcturus Therapeutics Holdings Inc's Revenue forecast?
Projected CAGR
-18%

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 3 years is -18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett